Lung cancer drug offers a surprising new treatment against ovarian cancer
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Lung cancer drug offers a surprising new treatment against ovarian cancer
Repurposed alcoholism drug fights liver cancer by targeting fat metabolism and blood supply
Antibody-drug conjugate achieves high response rates as frontline treatment in aggressive, rare blood cancer
HPV cancer vaccine slows tumour growth, extends survival in preclinical model
Overall survival benefit with elenagen plus gemcitabine in platinum-resistant ovarian cancer
ASH publishes clinical practice guidelines on frontline and relapsed/refractory management of all in adolescents and young adults
Call for action on understudied lung cancer in never-smokers
Virus-based therapy boosts anti-cancer immune responses to brain cancer
The European Cancer Organisation welcomes European Parliament resolution on cancer
New study shows how to protect the brain to prevent depression and cognitive impairment caused by whole brain radiotherapy
FDA approves pembrolizumab with paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
New dual-action compound reduces pancreatic cancer cell growth